Nateglinide
Drug Status in USA : Approved
Drug Status in Canada : Approved
Indication : Why is this medication prescribed?
Type II diabetes mellitus.
Contraindication: What are the special precautions to be followed?
Under following conditions, use of this medication is inadvisable. Its use should be withhold as it would cause harm to the patient
Hypersensitivity. Diabetic ketoacidosis. Type I diabetes mellitus. Pregnancy and lactation.Other Precaution to be observed while taking this medication
Hypoglycemia Geratric patients, malnourished patients. Adrenal or pituitary insufficiency. Strenuous physical exercise, ingestion of alcohol, insufficient caloric intake. Moderate to severe hepatic or renal impairment.
What are possible side effects of this medication ?
Dizziness, diarrhoea, nausea, hypoglycemia, back pain, arthropathy, upper respiratory tract infection, bronchitis, coughing, flu like symptoms, accidental injuries.
Drug Category/Class
- Hypoglycemic Agents
- Meglitinides
- Drugs Used in Diabetes
- Alimentary Tract and Metabolism
- Blood Glucose Lowering Drugs, Excl. Insulins
- Cytochrome P-450 CYP2C9 Inhibitors
- Cytochrome P-450 CYP2C9 Inducers
- CYP2D6 Inducers
- CYP2D6 Inducers (strong)
- CYP3A4 Inhibitors
- Other blood glucose lowering drugs, excl. insulins
| Prescribed | For the treatment of non-insulin dependent-diabetes mellitus in conjunction with diet and exercise. |
| Weight : | 317.4226 |
| Structure | Nateglinide |
 |
| Formula | C19H27NO3 |
Nateglinide has 10 Brands listed
Search Generic Drugs alphabetically